Vivek Ramaswamy

10% owner · Roivant Sciences

Vivek Ramaswamy (10% owner) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $67.9M of ROIV (3,103,745 sh across 3 lots, as filed), executed Dec 11 2025. Data as of Nov 7 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$67.9M

shares × price, as filed

Last traded

Dec 15 2025

Filed Dec 15 2025

Median ADV $222.0M across their filed names

Open performance→

Volume by month

Buys $1.2M Sells $160.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

ROIV

Roivant Sciences Ltd. ROIV · 0 buys · 6 sells 6 filings ASST

Strive, Inc. ASST · 1 buy · 0 sells 1 filing

Recent filings

ROIVSALE Roivant Sciences Ltd. View filing → $67.9M
3,103,745 sh across 3 lots
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $37.9M
1,854,603 sh across 3 lots
Exec Nov 13 2025
Filed Nov 17 2025 · 5:30 PM ET ASSTPURCHASE Strive, Inc. View filing → $1.2M
15,625 sh × $80.00
Exec Nov 5 2025
Filed Nov 7 2025 · 6:50 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $22.5M
1,775,749 sh across 3 lots
Exec Sep 3 2025
Filed Sep 5 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $13.1M
1,142,273 sh across 2 lots
Exec Jun 18 2025
Filed Jun 23 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $8.5M
748,230 sh across 2 lots
Exec Jun 4 2025
Filed Jun 6 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $10.1M
898,959 sh across 2 lots
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET